United States · Funded startup

Who invested in Inhibrx

3 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Raised 8 months ago

Funding summaryUpdated 26 Oct 2026

$265Mraised across 3 rounds since 2019, from 3 sources

$40MRound$150MDebt$75MDebt
Latest round
Debt, $75MMar 2026
Biggest round
$150MDebt · Jan 2025
Investors
6
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20192020202120222023202420252026
$40MRound$150MDebt$75MDebt
First round
Round, $40M
May 2019
Biggest round
$150M
Debt · Jan 2025
Usual gap between rounds
5.6 years
the median of 2

The rounds

  1. Mar 2026
  2. Jan 2025
  3. May 2019
    Round$40M1 new

    Reported by FinSMEsSEC filing: $40M sold, first sale May 2019

Founders and team

From the SEC filings it signed: 3 on the team.

  • Brendan EckelmanExecutive Officeri
  • Kelly DeckExecutive Officeri
  • Mark LappeExecutive Officer, Directori

On the board, as filediDouglas ForsythJon KayyemKimberly ManhardKristiina Vuori

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

RA Capital ManagementPrivate equity2rounds
Perceptive AdvisorsAsset manager2rounds
Lilly Asia VenturesVC firm2rounds
TCGPrivate equity2rounds
TCG CrossoverVC firm2rounds
Viking GlobalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Inhibrx

Who invested in Inhibrx?

Inhibrx's investors include RA Capital Management, Perceptive Advisors, Lilly Asia Ventures, TCG and TCG Crossover, and 1 more on record.

How much has Inhibrx raised?

Inhibrx has raised $265M across 3 rounds since 2019.

When did Inhibrx last raise?

Inhibrx's most recent round was a Debt of $75M in Mar 2026.

What was Inhibrx's biggest round?

Inhibrx's largest round on record is $150M (Debt), in Jan 2025.

Who backed Inhibrx first?

Inhibrx's first round on record, in May 2019, was backed by Viking Global.

What stage is Inhibrx at?

Inhibrx's latest named round is a Debt, in Mar 2026.

Where is Inhibrx based?

Inhibrx is based in the United States.

Companies like Inhibrx

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.